About SPB

Swiss Plasmabiotech GmbH

Plasmabiotech is a biotech company with an innovative vision and a dedication to developing new products in the field of regenerative medicine. We are the developer, manufacturer, and distributor of patented SPB PRP products for autologous blood plasma therapy.

The company is leading a paradigm shift in autologous plasma therapies. Plasmabiotech is headquartered in Schwerzenbach, ZH, near Zurich.

Core Values

Leadership & Management

Consists of an experienced and well-balanced team with complementary skill sets. The Chairman and Chief Executive Officer is Ihsan Yalcin, a Swedish national who has extensive experience in business strategy development and global management. He holds a Bachelor’s degree in Economics and a Bachelor of Science degree in International Business Management from Karlstad University.

Vision & Mission

People are at the heart of everything we do. We strive to make a difference in the field of regenerative medicine for the benefit of patients. With expertise, care, and persistence, we aim to be a leading provider of autologous plasma therapy products. We focus on providing a comprehensive, future-oriented service to provide a foundation for long-term business relations.

Quality & Reliability

Quality is not just a statement, but part of our daily commitment. Our PRP product is certified in accordance with EN ISO 13485 and is classified as a Class IIa medical device under Directive 93/42/EEC. This means that the plasma obtained using the device can be injected immediately after centrifugation into the body. The product is also manufactured according to GMP standards.
Locations

We Are World Wide Available

40+ Countries

figure